Related Experiment Video

Updated: May 17, 2026

Point-of-Care Lung Ultrasound in Adults: Image Acquisition
09:17

Point-of-Care Lung Ultrasound in Adults: Image Acquisition

Published on: March 3, 2023

Pleural fluid MDA and serum-effusion albumin gradient in pleural effusion

Manaswini Mangaraj1, S Kumari, R Nanda

  • 1Department of Biochemistry, S.C.B. Medical College, Duplex No.30, Sector-6, Bhawani constructions, Near IPSAR, Bidanasi, Cuttack. Pin, 753014 Orissa India.

Indian Journal of Clinical Biochemistry : IJCB
|October 30, 2012
PubMed

Insights

Pleural fluid malondialdehyde (PMDA) and serum effusion albumin gradient (SEAG) effectively differentiate pleural effusion types. These markers, especially PMDA, show promise in improving diagnostic accuracy beyond Light's criteria for exudates versus transudates.

Area of Science:

  • Pulmonology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Pleural effusion diagnosis relies on differentiating transudates and exudates.
  • Light's criteria are standard but can be limited in borderline cases.
  • Biochemical markers may offer improved diagnostic capabilities.

Purpose of the Study:

  • To evaluate pleural fluid malondialdehyde (PMDA) and serum effusion albumin gradient (SEAG) for distinguishing pleural effusion types.
  • To compare the diagnostic performance of PMDA and SEAG with Light's criteria.

Main Methods:

  • Sixty patients with diverse pleural effusion etiologies were studied.
  • PMDA and SEAG levels were measured and compared to Light's criteria.
  • Statistical analysis assessed correlations and diagnostic accuracy.

Main Results:

  • Mean PMDA levels were significantly higher in exudates (1.17±0.25 nmol/ml) than transudates (0.68±0.24 nmol/ml).
  • SEAG levels were significantly lower in exudates compared to transudates (P<0.001).
  • PMDA demonstrated better sensitivity and specificity than Light's criteria; SEAG showed comparable performance.

Conclusions:

  • PMDA and SEAG are valuable biochemical markers for differentiating pleural effusions.
  • Combining PMDA and SEAG with Light's criteria can enhance diagnostic discrimination, particularly in ambiguous cases.
Keywords:
ExudatesPleural FluidTransudates

More Related Videos

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica03:32

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica

Published on: April 12, 2019

Related Concept Videos

Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
Ascites01:19

Ascites

DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...